**Core tip:** Reconstruction of tracheal defects has historically been difficult, predominantly due to the lack of an intrinsic blood supply. Direct anastomosis is generally considered to be the best option. For larger defects, stenting and prosthetic reconstruction remain the primary methodologies. In light of the recent scandal surrounding tracheal replacement, this article aims to give a historical review of tracheal reconstruction methods.

INTRODUCTION
============

Tracheal reconstruction has been widely researched over the last 50 years. There are numerous indications for tracheal reconstruction, most frequently post-intubation injuries, idiopathic stenosis, neoplasia and re-stenosis following surgery\[[@B1]\].

Following tracheal resection, primary reconstruction with direct anastomosis of the patient's own tracheobronchial tissue is generally accepted as the best option\[[@B2]-[@B7]\]. Anatomical studies suggest that up to half of the trachea can be resected in adults and directly anastomosed, without undue tension, by implementing mobilisation techniques such as suprahyoid release incisions and/or dissection of the hilum and pulmonary ligament\[[@B8]\]. This has been corroborated in large studies, with acceptable safety profiles and good long-term results, although the limits vary depending upon the patient's age, body habitus, local anatomy, co-morbidities and previous treatments\[[@B1],[@B9]-[@B12]\].

In patients with very extensive pathology, direct anastomosis following resection is not possible and as such, either stenting or replacement with a prosthesis remain the two principle options. This provides a sig--nificant subset of patients. For example, long-segment defects (greater than 50% of the trachea) constitute approximately half of tracheal stenosis cases, although more recently this has been innovatively and successfully managed *via* a slide tracheoplasty procedure\[[@B13],[@B14]\]. A range of materials have been attempted and no ideal prosthesis has yet been developed. The ideal prosthesis is airtight, of adequate consistency to prevent collapse, well accepted by the host thus causing minimal inflammatory reaction, impervious to fibroblastic and bacterial invasion of the lumen and allows ingrowth of respiratory epithelium along the lumen\[[@B15],[@B16]\].

In this review article we will provide a historical overview of tracheal reconstructive trends.

EARLY WORK
==========

In the late 1890s and into the twentieth century, interest in tracheal reconstruction evolved\[[@B17]-[@B20]\]. Initially, as with many surgical specialities, a knowledge base was formed principally through isolated case reports. The focus at this time was autogenous replacements such as skin alone, or skin and fascial grafts\[[@B21],[@B22]\]. Daniel et al\[[@B23]\] heralded the advent of a more scientific approach with experimental animal studies. Throughout this period there was a transition from autogenous materials to solid prostheses such as tantalum, polyethylene, acrylic and steel tubes\[[@B24]-[@B27]\]. No ideal prosthesis was found and outcomes were variable. Indeed, often composite approaches were taken, usually in the form of a solid prosthesis with fascia lata grafts. The level of evidence remained low.

1950s TO THE POROUS PROSTHESIS
==============================

Following this initial interest and *in vivo* work (Table [1](#T1){ref-type="table"}), Gebauer was amongst the first to develop porous prostheses to counteract some of the drawbacks of solid prostheses\[[@B28],[@B29]\]. It was found that a porous prosthesis more closely approximates the function of tracheal cartilages as compared to a solid prosthesis\[[@B30]\]. However complications including strictures, granulation formation, chronic infection, pressure necrosis from the prosthesis and dislodgement remained problematic. Erosion of the brachiocephalic artery was also not infrequent. The porous structure was calculated to permit ingrowth of host connective tissue thus incorporating the prosthesis into the tracheal site; it was found that a minimal porosity of 40 to 60 μm is necessary for capillary ingrowth\[[@B31]\]. There was a proliferation of literature and animal studies in this field during the 1950s and 1960s\[[@B32]-[@B36]\]. This culminated in a better understanding of an ideal prosthesis in that the graft should be airtight, have adequate consistency, be well accepted by the host, cause minimal inflammatory reaction, be impervious to fibroblastic and bacterial invasion into the lumen but ideally allow ingrowth of respiratory epithelium along the lumen\[[@B15],[@B33],[@B35]\]. The decision of material to trial was often dependent upon industrial and commercial advances and availability, ranging from steel wire, tantalum, marlex, PTFE, dacron and teflon\[[@B2],[@B29]-[@B36]\]. Combinations of materials were often employed. Towards the end of this period, as a result, prosthetic reconstruction of the trachea was being performed in human patients\[[@B37],[@B38]\]. The most promising outcomes were with Silicone prostheses. The Neville group pioneered this approach and developed the Neville prosthesis, a silicone based mould under high compression available as straight or bifurcated tubes\[[@B15],[@B16]\]. In this series of 62 patients, outcomes were reported to be good and the use of silicone was explicated by its resilience, non-reactivity, smooth inner surface and ability to be readily moulded\[[@B15],[@B39]\]. This, therefore, fulfilled all the criteria for an ideal graft except for ciliated epithelium traversing the inner surface. Suture line granulomas remained problematic and were treated endoscopically\[[@B15],[@B16],[@B37]\]. This connective tissue ingrowth initially serves to fix and integrate the porous prostheses but this continued proliferation leads to scar tissue, obstruction and stenosis alongside with resultant chronic infection\[[@B31]\].

###### 

Tracheal reconstruction methodology over time

  **Year**   **First author**        **Category[1](#T1FN1){ref-type="table-fn"}**   **Material**                                                **Study type (number)**
  ---------- ----------------------- ---------------------------------------------- ----------------------------------------------------------- -------------------------
  1898       Bruns\[[@B17]\]                                                        Prosthesis unknown                                          Human
  1911       Hohmeier\[[@B18]\]      Autogenous                                     Fascia lata                                                 Animal
  1912       Levit\[[@B19]\]         Autogenous                                     Fascia                                                      Human (1)
  1927       Fairchild\[[@B20]\]     Autogenous                                     Skin                                                        Human (1)
  1935       LeJeune\[[@B21]\]       Autogenous                                     Split thickness skin graft                                  Human (2)
  1945       Crafoord\[[@B22]\]      Autogenous                                     Cutaneous and costal cartilage                              Human (1)
  1946       Belsey\[[@B24]\]        Solid prosthesis                               Steel with fascia lata                                      Human (1)
  1948       Clagett\[[@B25]\]       Solid prosthesis                               Polyethylene                                                Human (1)
  1948       Daniel\[[@B23]\]        Solid prosthesis                               Fascia, Metal Tube                                          Animal
  1948       Longmire\[[@B26]\]      Solid prosthesis                               Acrylic tube                                                Human (1)
  1949       Rob\[[@B27]\]           Solid prosthesis                               Tantalum with fascia lata                                   Human (4)
  1949       Kergin                  Autogenous                                     Pericardium and bronchus                                    Human (1)
  1950       Jarvis                  Solid prosthesis                               Stainless Steel                                             Human (1)
  1950       Gebauer\[[@B29]\]       Porous prosthesis                              Wire-enforced dermal graft                                  Human (11)
  1951       Bucher\[[@B30]\]        Porous prosthesis                              Stainless steel wire mesh                                   Animal
  1952       Cotton\[[@B2]\]         Solid prosthesis                               Stainless steel tube                                        Human (2)
  1953       Edgerton                Solid prosthesis                               Split grafts with foam rubber                               Human (12)
  1953       Pressman\[[@B32]\]      Autogenous                                     Decalcified bone                                            Animal
  1955       Morfit                  Solid prosthesis                               Polyethylene                                                Animal
  1962       Beall\[[@B35]\]         Solid prosthesis                               Polyethylene                                                Animal
  1964       Aletras                 Solid prosthesis                               Teflon frame with pericardium                               Animal
  1967       Graziano\[[@B33]\]      Porous prosthesis                              Silicon with dacron                                         Animal
  1968       Pearson\[[@B34]\]       Porous prosthesis                              Marlex (Polyethylene)                                       Animal
  1973       Monk                    Autogenous                                     Dermal grafts                                               Human (6)
  1973       Demos                   Porous prosthesis                              Silicone                                                    Animal
  1974       Montgomery\[[@B38]\]    Porous prosthesis                              Silicone t tube                                             Human (94)
  1974       Pearson                 Porous prosthesis                              Marlex (Polyethylene)                                       Human (6)
  1976       Neville\[[@B37]\]       Porous prosthesis                              Silicone                                                    Human (26)
  1977       Lindholm                Autogenous                                     Bone/periosteum/muscle                                      Human (2)
  1982       Neville\[[@B15]\]       Porous prosthesis                              Neville prosthesis (silicon with dacron rings)              Human (54)
  1982       Westaby                 Porous prosthesis                              Bifurcated silicone stent                                   Human (1)
  1985       Toomes\[[@B6]\]         Porous prosthesis                              Neville prosthesis (silicon with dacron rings)              Human (9)
  1986       Scherer\[[@B67]\]       Tissue engineering                             Bioprosthesis                                               Animal
  1989       Har-El                  Autogenous                                     Alloplast implanted muscle flap                             Animal
  1990       Neville\[[@B39]\]       Porous prosthesis                              Silicone tubes                                              Human (62)
  1990       Cull                    Porous prosthesis                              PTFE                                                        Animal
  1990       Jorge                   Porous prosthesis                              PTFE                                                        Animal
  1990       Kato\[[@B66]\]          Autogenous                                     Oesophagus and Silicone T tube                              Animal
  1990       Letang\[[@B65]\]        Homograft                                      Jejunum and Silicone T tube                                 Animal
  1990       Varela                  Porous prosthesis                              Stainless steel wire mesh                                   Human (5)
  1992       East\[[@B64]\]          Autogenous                                     Composite fascia, septum                                    Human (1)
  1994       Okumura\[[@B63]\]       Porous prosthesis                              Collagen and Marlex mesh                                    Animal
  1996       Sharpe                  Porous prosthesis                              Marlex and pericardium                                      Human (1)
  1996       Elliott\[[@B62]\]       Homograft                                      Homograft                                                   Human (5)
  1997       Kiriyama\[[@B61]\]      Homograft                                      Oesophageal autograft                                       Animal
  1997       Teramachi\[[@B60]\]     Porous prosthesis                              Marlex with collagen                                        Animal
  2000       Sekine\[[@B59]\]        Porous prosthesis                              Marlex                                                      Animal
  2003       Pfitzmann\[[@B58]\]     Homograft                                      Oesophagus                                                  Human (1)
  2004       Kim\[[@B57]\]           Porous prosthesis                              Skin and polypropylene mesh                                 Animal
  2005       Martinod\[[@B56]\]      Homograft                                      Allogenic aorta                                             Animal
  2005       Shi\[[@B55]\]           Porous prosthesis                              Polyprophyelene mesh with polyurethane/collagen             Animal
  2006       Jaillard\[[@B54]\]      Homograft                                      Allograft aorta                                             Animal
  2008       Sato\[[@B53]\]          Porous prosthesis                              Polyprophyelene mesh with collagen                          Animal
  2008       Macchiarini\[[@B79]\]   Homograft                                      Stem cell seeded homograft                                  Human
  2009       Nakamura\[[@B51]\]      Porous prosthesis                              Polyprophlene with additional collagen, stem cells          Animal
  2010       Makris\[[@B50]\]        Homograft                                      Allograft aorta                                             Animal
  2010       Sato\[[@B49]\]          Tissue engineering                             Bioprosthesis                                               Animal
  2010       Tsukada\[[@B74]\]       Tissue engineering                             Bioprosthesis                                               Animal
  2011       Yu\[[@B47]\]            Autogenous/prosthesis                          Radial forearm flap with PTFE or polyethlene                Human (7)
  2011       Jungebluth\[[@B48]\]    Tissue engineering                             Stem cell bioartificial scaffold                            Human (1)
  2012       Elliott\[[@B46]\]       Tissue engineering                             Stem cell bioartificial scaffold                            Human (1)
  2012       Gray\[[@B45]\]          Tissue engineering                             Stem cell bioartificial scaffold                            Animal
  2012       Tani                    Tissue engineering                             Collagen scaffold with FGF                                  Animal
  2012       Wurtz\[[@B77]\]         Homograft                                      Allograft aorta with fascial graft and external cartilage   Animal
  2014       Chang\[[@B40]\]         Tissue engineering                             Stem cell bioartificial (3D Printed) scaffold               Animal
  2016       Delaere\[[@B78]\]       Allotransplant                                 Vascularised allograft                                      Human

A number of these are composite strategies. PTFE: Polytetrafluoroethylene; FGF: Fibroblast growth factor.

At this time, progress was also being made in surgical techniques, led by Grillo's team in Boston. Anatomic studies indicated that up to half the trachea in adults can be resected and closed primarily with an end to end anastomosis\[[@B8]\]. The same group has validated this with resulting large case series with low morbidity and mortality\[[@B3],[@B4],[@B9]-[@B11],[@B13],[@B31]\]. Slide tracheoplasty and other mobilisation techniques including suprahyoid release incisions, dissection of the hilum and pulmonary ligament have all been successfully used to achieve primary closure. Undoubtedly this remains the gold standard management of tracheal resection. However, it is not always possible and is dependent upon the patient's age, body habitus, local anatomy, extent of disease, co-morbidities and previous treatments such as radiotherapy\[[@B3],[@B4],[@B9]-[@B11],[@B13],[@B31]\].

These studies therefore established that primary repair remains the method of choice and should be employed wherever possible. In addition, it was concluded that an entirely satisfactory tracheal graft will never be available\[[@B31],[@B35]\]. The silicone airway is at least as satisfactory as any prosthesis yet fashioned for tracheal replacement and any alternative must be wholly dependable with minimal morbidity and mortality\[[@B31]\]. This remains the case today.

1990s ONWARDS
=============

Further avenues of research have evolved in the last few decades. This has focussed on homografts, various composite strategies (including further work on porous prostheses) and latterly, tissue engineering\[[@B1],[@B5],[@B9],[@B10],[@B12],[@B14],[@B40]-[@B67]\].

Scherer et al\[[@B67]\] were first to experiment with bioprostheses by transplanting tracheas from various animals as autografts, allografts and xenografts. Rejection seemed to be avoided\[[@B31],[@B67]\]. This preceded a plethora of animal studies, particularly transplantation studies, and in the last few years, attempts to translate this to patients\[[@B40],[@B41],[@B43],[@B44],[@B49],[@B50],[@B54],[@B56],[@B61]\]. Recently, research has focused on tracheal stem cell regeneration. Despite initial positive results, the outcomes have been generally poor and as such should be used with caution\[[@B42]\]. Pedicled flaps may serve to implant and maintain the stem cell generated trachea prior to reconstruction\[[@B41]\]. A recent pilot study has used three-dimensional printing of an artificial tracheal graft\[[@B40]\]. In addition, there has been some focus on the use of intestinal (either jejunal or oesophageal) tubes to replace the trachea\[[@B66]\]. This autogenous tissue reconstruction can be categorised into free grafts with and without foreign material support (*e.g*., the composite wire and fascia or dermal grafts); vascularised tissue flaps (*e.g*., pedicled intercostal muscle) and autogenous tube construction (*e.g*., oesophagus)\[[@B31]\]. Autologous tracheal replacement using radial forearm fasciocutaneous free flap has also demonstrated positive outcomes\[[@B68]\].

Further homografts include pericardium and aorta\[[@B50],[@B54],[@B56]\]. Patch repair of the trachea using pericardial allografts\[[@B69]\] and xenografts\[[@B70]\] have been shown to have good outcomes\[[@B71]\]. More recently, aortic homografts used as a bioprosthetic device for patch repair have also shown favourable results\[[@B72],[@B73]\]. Circumferential replacement of the trachea using aortic allografts has shown poorer results, in both animal\[[@B74]\] and human\[[@B75]\] models. Wurtz demonstrated that silicone-stented aortic allografts have no cartilage regeneration, probably due to ischaemia prior to neoangiogenesis\[[@B76]\]. This led to proposals of a composite, fascial flap-wrapped allogeneic aortic graft with external cartilage ring support\[[@B77]\]. Again, no reconstruction has been as successful as direct anastomosis, or even silicone prostheses alone.

CONTROVERSIES AND FUTURE DEVELOPMENTS
=====================================

The intriguing yet unsolved surgical dilemma of tracheal replacement remains a challenge to clinicians. Currently, work from the Leuven group (Delaere et al\[[@B78]\]) have shown promising results with the judicious use of allotransplants. Surgical ingenuity will lead to novel approaches to these problems\[[@B3]\]. However, it is important to note that these techniques should not create more problems than they solve and patients are to be treated as an individual with a duty of care attached to that. As a corollary to this, it is worth highlighting that where a series of animal experiments are successful, application of these procedures to humans almost inevitably presents greater issues and a higher failure rate\[[@B3]\]. Work on tracheal regeneration using stem-cell implanted scaffolds\[[@B44],[@B48],[@B79]\], which has been the centre of recent controversy, showed questionable data and ultimately poor results.

CONCLUSION
==========

Direct revascularisation of the trachea is unsuitable due to its lack of an intrinsic blood supply. Its anatomical features (proximity to major vessels, segmental blood supply) and the presence of a variety of different tissue types (respiratory epithelium, cartilage, blood vessels) make reconstruction difficult. Recent attempts with tissue-engineered transplants have all failed due to this reason\[[@B80]\]. Tracheal reconstruction is optimal when primary anastomosis is possible with undue tension. Patients requiring reconstruction should be managed in a multidisciplinary team at a high volume tertiary referral centre to optimise treatment. Tracheal replacement can be divided into prosthesis, homograft and autogenous tissue reconstruction, or a combinatorial methodology. None have proven ideal conduits as tracheal replacements. The most convincing evidence has historically been silicone based prostheses, and more recently revascularised tracheal homografts and allotransplants. Stenting of the trachea has shown poor results. In emergent situations, endobronchial debulking and laser is preferable over stenting as this may prevent primary surgery.
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